ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
대상포진 백신 시장 규모는 최근 급성장하고 있습니다. 2025년 55억 5,000만 달러에서 2026년에는 63억 7,000만 달러에 이르고, CAGR 14.8%의 성장이 전망되고 있습니다. 지금까지의 성장은 대상포진 백신공급 제한, 약독성 생백신 의존도, 고령 인구 증가, 대상포진 발병률 상승, 예방접종 혜택에 대한 인식 증가 등이 원인으로 추정됩니다.
대상포진 백신 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 14.5%의 연평균 복합 성장률(CAGR)로 109억 6,000만 달러에 이를 전망입니다. 예측 기간 동안 성장 요인으로는 재조합 백신 및 아단위 백신의 개발, 공공 및 민간 예방접종 캠페인의 확대, 온라인 및 소매 약국 유통의 채택 증가, 노인 예방접종에 대한 정부 및 의료기관의 노력 강화, 예방접종 준수를 위한 디지털 건강 모니터링의 통합 등이 있습니다. 건강 모니터링의 통합 등이 있습니다. 예측 기간 동안 주요 동향으로는 재조합 및 서브유닛 대상포진 백신의 채택 증가, 고령층의 대상포진 예방에 대한 인식 증가, 병원 및 소매 약국을 통한 예방접종 프로그램 확대, 온라인 약국 및 전자상거래를 통한 백신 유통 성장, 50세 이상 연령대별 예방접종 전략에 대한 집중 등이 있습니다. 연령별 예방접종 전략에 대한 집중을 들 수 있습니다.
백신 접종 프로그램의 확대는 향후 대상포진 백신 시장의 성장을 가속화할 것으로 예측됩니다. 백신 접종 프로그램은 전염병의 유행을 억제하기 위해 백신을 광범위하게 제공하기 위한 체계적인 공중보건 정책입니다. 이러한 성장은 예방의료에 대한 인식이 높아진 것을 반영하여 질병 예방을 위한 예방접종 확대를 촉진하고 있습니다. 백신 접종 프로그램은 인지도를 높이고 접근을 용이하게 함으로써 고령자 및 고위험군에 적합한 대상포진 백신의 이용을 촉진합니다. 신속하고 광범위한 예방접종으로 대상포진 발병 위험과 합병증을 줄여 지역사회 건강 증진에 기여합니다. 예를 들어, 스위스에 본부를 둔 국제보건기구인 세계보건기구(WHO)는 2025년 7월, 여아에 대한 인간유두종바이러스(HPV) 백신 첫 접종률이 2023년 27%에서 2024년 31%로 상승했다고 보고했습니다. 이처럼 확대되는 백신 접종 프로그램이 대상포진 백신 시장을 주도하고 있습니다.
대상포진 백신 시장의 주요 기업들은 면역력을 높이고 지속적인 대상포진 방어력을 확보하기 위해 재조합 보조제 첨가 백신과 같은 새로운 제형 개발을 추진하고 있습니다. 재조합 보조제 첨가 백신은 설계된 바이러스성분과 면역증강제를 결합하여 우수한 장기 방어 효과를 얻을 수 있습니다. 예를 들어, 2023년 4월 인도에 본사를 둔 제약회사 글락소 스미스클라인(GlaxoSmithKline)은 대상포진 백신 '신글릭스(Syngrix)'를 발표했습니다. 이 비생백신인 재조합 보조제 첨가 아단위 백신은 50세 이상 성인을 대상으로 대상포진(헤르페스 조스터)과 그 합병증인 대상포진 후 신경통을 예방하기 위해 2회 근육접종으로 접종합니다. 90% 이상의 효능을 자랑하며, 노약자나 면역력이 저하된 분들에게도 10년 이상 강력한 예방 효과를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Shingles vaccine is a preventive immunization aimed at protecting against shingles (herpes zoster), a painful skin condition caused by the reactivation of the varicella-zoster virus. It stimulates the immune system to recognize and combat the virus, reducing the risk of developing shingles and its related complications.
The main types of shingles vaccines are live attenuated vaccines, recombinant vaccines, and subunit vaccines. A live attenuated vaccine contains a weakened form of the live pathogen that can replicate without causing disease, eliciting a strong and lasting immune response. Product examples include Shingrix, Zostavax, and SkyZoster, primarily administered to individuals aged 50-59 years, 60-69 years, and 70 years and above. These vaccines are distributed through hospital pharmacies, online pharmacies, and retail pharmacies, serving end users such as hospitals, clinics, and pharmacies.
Tariffs have influenced the shingles vaccine market by increasing costs of imported vaccines, vaccine components, and cold chain logistics equipment. Segments like recombinant and subunit vaccines are most affected, particularly in regions like North America and Europe where import dependency is high. This has led to higher vaccine costs and potential supply delays. On the positive side, tariffs have encouraged local vaccine production, innovation in cold chain and distribution solutions, and improved domestic availability of shingles vaccines.
The shingles vaccine market research report is one of a series of new reports from The Business Research Company that provides shingles vaccine market statistics, including shingles vaccine industry global market size, regional shares, competitors with a shingles vaccine market share, detailed shingles vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the shingles vaccine industry. This shingles vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The shingles vaccine market size has grown rapidly in recent years. It will grow from $5.55 billion in 2025 to $6.37 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to limited availability of shingles vaccines, reliance on live attenuated vaccines, growing elderly population, increasing incidence of herpes zoster, rising awareness of immunization benefits.
The shingles vaccine market size is expected to see rapid growth in the next few years. It will grow to $10.96 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to development of recombinant and subunit vaccines, expansion of public and private vaccination campaigns, increasing adoption of online and retail pharmacy distribution, rising government and healthcare initiatives for elderly immunization, integration of digital health monitoring for vaccination adherence. Major trends in the forecast period include rising adoption of recombinant and subunit shingles vaccines, increasing awareness of shingles prevention among older adults, expansion of vaccination programs through hospital and retail pharmacies, growth in online pharmacies and e-commerce vaccine distribution, focus on age-specific immunization strategies for 50+ population.
The expanding scope of vaccination programs is set to accelerate the shingles vaccine market ahead. Vaccination programs are structured public health efforts to deliver vaccines broadly, curbing infectious disease outbreaks. Their growth reflects heightened preventive health consciousness, spurring wider uptake to dodge illnesses. Vaccination programs boost shingles vaccine use by raising visibility and ease of access, suiting seniors and at-risk groups. They cut shingles odds and issues via prompt, broad shots, lifting community wellness. For example, in July 2025, the World Health Organization, a Switzerland-based global health body, noted first-dose human papillomavirus (HPV) vaccine coverage for girls climbed from 27% in 2023 to 31% in 2024. Thus, the rising vaccination programs are propelling the shingles vaccine market.
Leading companies in the shingles vaccine market are advancing novel formulas like recombinant adjuvanted vaccines to amplify immunity and ensure enduring shingles defense. Recombinant adjuvanted vaccines blend engineered viral elements with immune boosters for superior, prolonged shielding. For instance, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharma firm, introduced Shingrix, a shingles shot. This non-live, recombinant adjuvanted subunit vaccine goes in via two intramuscular doses for adults 50+, targeting shingles (herpes zoster) and its fallout, post-herpetic neuralgia. Boasting over 90% efficacy, it delivers robust, decade-plus protection, even for elderly or weakened immune systems.
In October 2023, GSK plc, a UK healthcare tech leader, joined forces with Chongqing Zhifei Biological Products Co. Ltd. for exclusive Shingrix distribution and promotion in China. This pact ramps Shingrix reach across 30,000+ sites while laying groundwork for co-building and selling GSK's RSV vaccine (Arexvy) to Chinese seniors. Chongqing Zhifei Biological Products Co. Ltd. is a China biotech expert in crafting, making, and spreading cutting-edge vaccines.
Major companies operating in the shingles vaccine market are Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc
North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the shingles vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The shingles vaccine market consists of sales of vaccine kits, cold chain storage equipment, pre-filled syringes, vaccine delivery devices, and temperature monitoring systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Shingles Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses shingles vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for shingles vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The shingles vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Vaccine Type: Live Attenuated Vaccine; Recombinant Vaccine; Subunit Vaccine
2) By Product: Shingrix; Zostavax; Skyzoster
3) By Age Group: 50-59 Years; 60-69 Years; 70 Years And Above
4) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
5) By End User: Hospitals; Clinics; Pharmacies
Subsegments:
1) By Live Attenuated Vaccine: Virus Strain A; Virus Strain B; Virus Strain C
2) By Recombinant Vaccine: Recombinant Protein Vaccine; Recombinant Vector Vaccine; Recombinant Deoxyribonucleic Acid Vaccine
3) By Subunit Vaccine: Protein Subunit Vaccine; Conjugate Subunit Vaccine
Companies Mentioned: Merck & Co. Inc.; GSK plc; SK bioscience; Pfizer Inc; GeneOne Life Science; Curevo Inc; Novavax Inc
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Adoption Of Recombinant And Subunit Shingles Vaccines
4.2.2 Increasing Awareness Of Shingles Prevention Among Older Adults
4.2.3 Expansion Of Vaccination Programs Through Hospital And Retail Pharmacies
4.2.4 Growth In Online Pharmacies And E-Commerce Vaccine Distribution
4.2.5 Focus On Age-Specific Immunization Strategies For 50+ Population
5. Shingles Vaccine Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Pharmacies
5.4 Online Pharmacies
5.5 Elderly Care Centers
6. Shingles Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Shingles Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Shingles Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Shingles Vaccine Market Size, Comparisons And Growth Rate Analysis
7.3. Global Shingles Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Shingles Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Shingles Vaccine Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Shingles Vaccine Market Segmentation
9.1. Global Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine
9.2. Global Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Shingrix, Zostavax, Skyzoster
9.3. Global Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
50-59 Years, 60-69 Years, 70 Years And Above
9.4. Global Shingles Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Shingles Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Pharmacies
9.6. Global Shingles Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Virus Strain A, Virus Strain B, Virus Strain C
9.7. Global Shingles Vaccine Market, Sub-Segmentation Of Recombinant Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine
9.8. Global Shingles Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Protein Subunit Vaccine, Conjugate Subunit Vaccine
10. Shingles Vaccine Market Regional And Country Analysis
10.1. Global Shingles Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Shingles Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Shingles Vaccine Market
12.1. China Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Shingles Vaccine Market
13.1. India Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Shingles Vaccine Market
14.1. Japan Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Shingles Vaccine Market
15.1. Australia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Shingles Vaccine Market
16.1. Indonesia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Shingles Vaccine Market
17.1. South Korea Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Shingles Vaccine Market
18.1. Taiwan Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Shingles Vaccine Market
19.1. South East Asia Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Shingles Vaccine Market
20.1. Western Europe Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Shingles Vaccine Market
21.1. UK Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Shingles Vaccine Market
22.1. Germany Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Shingles Vaccine Market
23.1. France Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Shingles Vaccine Market
24.1. Italy Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Shingles Vaccine Market
25.1. Spain Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Shingles Vaccine Market
26.1. Eastern Europe Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Shingles Vaccine Market
27.1. Russia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Shingles Vaccine Market
28.1. North America Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Shingles Vaccine Market
29.1. USA Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Shingles Vaccine Market
30.1. Canada Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Shingles Vaccine Market
31.1. South America Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Shingles Vaccine Market
32.1. Brazil Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Shingles Vaccine Market
33.1. Middle East Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Shingles Vaccine Market
34.1. Africa Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Shingles Vaccine Market Regulatory and Investment Landscape
36. Shingles Vaccine Market Competitive Landscape And Company Profiles
36.1. Shingles Vaccine Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Shingles Vaccine Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Shingles Vaccine Market Company Profiles
36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. GSK plc Overview, Products and Services, Strategy and Financial Analysis
36.3.3. SK bioscience Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
36.3.5. GeneOne Life Science Overview, Products and Services, Strategy and Financial Analysis
37. Shingles Vaccine Market Other Major And Innovative Companies
Curevo Inc, Novavax Inc
38. Global Shingles Vaccine Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Shingles Vaccine Market
40. Shingles Vaccine Market High Potential Countries, Segments and Strategies
40.1 Shingles Vaccine Market In 2030 - Countries Offering Most New Opportunities
40.2 Shingles Vaccine Market In 2030 - Segments Offering Most New Opportunities
40.3 Shingles Vaccine Market In 2030 - Growth Strategies
